Parasitic diseases represent one of the causes for significant global economic,
environmental and public health impacts. The efficacy of currently available anti-parasitic
drugs has been threatened by the emergence of single drug- or multidrug-resistant parasite
populations, vector threats and high cost of drug development. Therefore, the discovery of more
potent anti-parasitic drugs coming from medicinal plants such as Quercus infectoria is seen as a
major approach to tackle the problem. A systematic review was conducted to assess the efficacy
of Q. infectoria in treating parasitic diseases both in vitro and in vivo due to the lack of such
reviews on the anti-parasitic activities of this plant. This review consisted of intensive searches
from three databases including PubMed, Science Direct and Scopus. Articles were selected
throughout the years, limited to English language and fully documented. A total of 454 potential
articles were identified, but only four articles were accepted to be evaluated based on inclusion and
exclusion criteria. Although there were insufficient pieces of evidence to account for the efficacy
of Q. infectoria against the parasites, this plant appears to have anti-leishmanial, anti-blastocystis
and anti-amoebic activities. More studies in vitro and in vivo are warranted to further validate the
anti-parasitic efficacy of Q. infectoria.